lobbying_activities: 2638240

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2638240 394fe7b8-2c48-4c49-9875-b6b419b58abd Q2 COVINGTON & BURLING LLP 11195 ZYMERGEN INC. 2021 second_quarter MAN Enhanced investment in biomanufacturing; investment in workforce development, infrastructure, and R&D for synthetic biology; shoring up manufacturing supply chains for critical pharmaceutical ingredients; supporting government investment in mRNA-based technologies HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-07-15T14:40:39.937000-04:00